Skip to main navigation Skip to search Skip to main content

Engineered thiomarinol antibiotics active against MRSA are generated by mutagenesis and mutasynthesis of pseudoalteromonas SANK73390

  • Annabel C. Murphy
  • , Daisuke Fukuda
  • , Zhongshu Song
  • , Joanne Hothersall
  • , Russell J. Cox
  • , Christine L. Willis
  • , Christopher M. Thomas
  • , Thomas J. Simpson

Research output: Contribution to journalArticleResearchpeer review

Abstract

New drugs from marine bugs: The Japanese marine bacterium Pseudoalteromonas SANK73390 has been engineered to produce hybrid thiomarinol/pseudomonic acid compounds with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Previously unreported mupirocin and pyrrothine metabolites were isolated from wild-type and mutant strains and from mutagenesis experiments with mutant strains.

Original languageEnglish
Pages (from-to)3271-3274
Number of pages4
JournalAngewandte Chemie
Volume50
Issue number14
DOIs
Publication statusPublished - 28 Mar 2011
Externally publishedYes

UN Sustainable Development Goals (SDGs)

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 14 - Life Below Water
    SDG 14 Life Below Water

Keywords

  • antibiotics
  • biosynthesis
  • methicillin resistance
  • mupirocin
  • thiomarinol

ASJC Scopus subject areas

  • Catalysis
  • General Chemistry

Cite this